TLR4 and metabolic dysfunction-associated steatohepatitis: Additionally, Gallego et al. utilized AB-WE to treat non-alcoholic steatohepatitis (NASH) in rats, and found that feeding with AB-WE could increase the expression of anti-inflammatory factors (PPARα, TLR4), thereby achieving anti-inflammatory effects [49].